National Capital Surpluse from 2010 to 2024

NHC Stock  USD 105.84  0.92  0.88%   
National HealthCare's Capital Surpluse is increasing over the years with slightly volatile fluctuation. Capital Surpluse is expected to dwindle to about 234.7 M. During the period from 2010 to 2024 National HealthCare Capital Surpluse annual values regression line had geometric mean of  199,077,367 and mean square error of 221.5 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2011-06-30
Previous Quarter
225.9 M
Current Value
226.9 M
Quarterly Volatility
28.4 M
 
Yuan Drop
 
Covid
Check National HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National HealthCare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 25.8 M, Interest Expense of 307.8 K or Total Revenue of 709.3 M, as well as many indicators such as Price To Sales Ratio of 1.33, Dividend Yield of 0.0438 or PTB Ratio of 1.96. National financial statements analysis is a perfect complement when working with National HealthCare Valuation or Volatility modules.
  
Check out the analysis of National HealthCare Correlation against competitors.
For information on how to trade National Stock refer to our How to Trade National Stock guide.

Latest National HealthCare's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of National HealthCare over the last few years. It is National HealthCare's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National HealthCare's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

National Capital Surpluse Regression Statistics

Arithmetic Mean202,361,586
Geometric Mean199,077,367
Coefficient Of Variation18.13
Mean Deviation31,597,724
Median215,659,000
Standard Deviation36,679,978
Sample Variance1345.4T
Range106.1M
R-Value0.92
Mean Square Error221.5T
R-Squared0.85
Slope7,549,060
Total Sum of Squares18835.9T

National Capital Surpluse History

2024234.7 M
2023261 M
2022227 M
2021232.2 M
2020226.9 M
2019222.8 M
2018219.4 M

About National HealthCare Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include National HealthCare income statement, its balance sheet, and the statement of cash flows. National HealthCare investors use historical funamental indicators, such as National HealthCare's Capital Surpluse, to determine how well the company is positioned to perform in the future. Although National HealthCare investors may use each financial statement separately, they are all related. The changes in National HealthCare's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on National HealthCare's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on National HealthCare Financial Statements. Understanding these patterns can help to make the right decision on long term investment in National HealthCare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse261 M234.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in National Stock

When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:
Check out the analysis of National HealthCare Correlation against competitors.
For information on how to trade National Stock refer to our How to Trade National Stock guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.224
Dividend Share
2.36
Earnings Share
5.27
Revenue Per Share
75.942
Quarterly Revenue Growth
0.102
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.